Stoke Therapeutics (STOK) Free Cash Flow (QoQ) (2018 - 2026)
Stoke Therapeutics (STOK) Free Cash Flow (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,681.27 Bn | 66,680.98 Bn | - |
| 2 | Nanobiotix | 1,905.61 Bn | 1,905.55 Bn | - |
| 3 | Akari Therapeutics | 1,011.81 Bn | 1,011.81 Bn | - |
| 4 | BeOne Medicines | 467.29 Bn | 462.50 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.89 Bn | 115.65 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.28 Bn | 61.53 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.93 Bn | 62.93 Bn | - |
| 8 | Argenx Se | 55.90 Bn | 50.72 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.64 Bn | 34.63 Bn | 959.66 Mn |
| 10 | Stoke Therapeutics | 1.86 Bn | 1.51 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -96.36% |
| Dec 31, 2025 | -2.06% |
| Sep 30, 2025 | -19.50% |
| Jun 30, 2025 | -119.31% |
| Mar 31, 2025 | 663.61% |
| Dec 31, 2024 | -8.42% |
| Sep 30, 2024 | -23.04% |
| Jun 30, 2024 | 28.66% |
| Mar 31, 2024 | -17.69% |
| Dec 31, 2023 | -18.32% |
| Sep 30, 2023 | 22.06% |
| Jun 30, 2023 | -5.19% |
| Mar 31, 2023 | 2.57% |
| Dec 31, 2022 | -1.75% |
| Sep 30, 2022 | -9.41% |
| Jun 30, 2022 | -162.69% |
| Mar 31, 2022 | 291.49% |
| Dec 31, 2021 | -10.52% |
| Sep 30, 2021 | 8.54% |
| Jun 30, 2021 | 19.61% |